What makes a great BioELN?

28 June 2021
Posted in News | Tagged , ,

In this latest DDW whitepaper, brought to you by PerkinElmer Informatics, John Conway, is Chief Visioneer Officer at 20/15 Visioneers, tackles defining “What Makes a Great BioELN” in this thoughtful and informative industry perspective.

The whitepaper covers the six high-level workflows a great BioELN must include; what the team personas who must get utility from a new BioELN are; the three key qualities necessary to have in place before seeking a BioELN and much more.

Conway calls upon his extensive experience in the pharmaceutical industry and his degree in molecular biology to focus on much-needed change in Culture, Data, Processes, and Technology so that R&D companies can run more efficiently and embrace In-Silico advances.

Download here.

Suggested Reading

Learn what makes a great BioELN: Whitepaper
27 April 2022
Webinar: Next generation BioELN
28 March 2022

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free